Vunakizumab and Acitretin for Elderly Refractory Generalized Pustular Psoriasis: A Case Report and Comprehensive Literature Review
Shilin Deng, Yu Jiang, Wei Li, Zhirong Shu, Tingnan Chen, Jingyao Liang, Xibao Zhang · 2026
Read Vunakizumab and Acitretin for Elderly Refractory Generalized Pustular Psoriasis: A Case Report and Comprehensive Literature Review by Shilin Deng, Yu Jiang, Wei Li, Zhirong Shu, Tingnan Chen, Jingyao Liang, Xibao Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13207857.txt.
Description
Shilin Deng and co-authors report a 2026 case of a severe skin disease treated with a drug pairing not yet approved for it. The disease, generalized pustular psoriasis, covers the body in painful pustules and can threaten life. An approved drug targets one inflammation path, but access to it is limited.
Their patient was a 72-year-old man with forty years of plaque psoriasis whose disease turned pustular and resisted standard care. The team used vunakizumab, an antibody that blocks a signal called IL-17A, together with acitretin, an older skin drug. They pair the case with a wide review of past reports. The account gives skin doctors an option to weigh when approved drugs cannot be had.
Catalog record
| CREATOR | Shilin Deng, Yu Jiang, Wei Li, Zhirong Shu, Tingnan Chen, Jingyao Liang, Xibao Zhang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 19 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |